Danielle Daee, Ph.D.
- Ph.D. - Pathology and Microbiology with Cancer Research emphasis, University of Nebraska Medical Center
- B.S. - Biology, Minor Chemistry, Truman State University
- Pediatric and young adult cancers
- Prostate cancer
Dr. Danielle Daee is a Program Director in the Genomic Epidemiology Branch (GEB) of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). Her responsibilities include managing a portfolio of grants related to genetic factors modulating susceptibility to cancers, including prostate and pediatric cancers. Notably, Dr. Daee represents EGRP on the Gabriella Miller Kids First Pediatric Research Program working group and she is the scientific contact for the NCI funding opportunities for Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors R01(RFA-CA-027) and R21(RFA-CA-028). She also supports the assessment and evaluation of several ongoing EGRP initiatives.
Prior to joining EGRP, Dr. Daee was a Health Science Analyst in NCI's Office of Science Planning and Assessment (OSPA). In this position, she evaluated the impact of NCI’s research investments through program evaluations and portfolio analyses.
Dr. Daee was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) at NIH before joining NCI. During her research career, Dr. Daee developed an expertise in a variety of areas including DNA repair, DNA replication, and yeast genetics.
See listing of articles authored by Dr. Daee in PubMed.